Đang chuẩn bị liên kết để tải về tài liệu:
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: A case-control study

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The Metabolic syndrome (MetS) is an emerging condition worldwide, consistently associated with an increased risk of several cancers. Some information exists on urothelial carcinoma of the bladder (UCB) and MetS. This study aims at further evaluating the association between the MetS and UCB. |

TÀI LIỆU LIÊN QUAN

Metabolic syndrome biomarkers and early breast cancer in Saudi women: Evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk

Newborn weight change and childhood cardio-metabolic traits – a prospective cohort study

Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors

Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the West Virginian population

Mediterranean-style diet reduces metabolic syndrome components in obese children and adolescents with obesity

Interplay between 3′-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans

Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: A one sample Mendelian randomization study

Use of HbA1c in the diagnosis of metabolic syndrome

Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: A large prospective study

Neck circumference as a predictor of metabolic syndrome, insulin resistance and low-grade systemic inflammation in children: The ACFIES study